PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology.
Saved in:
| Title: | PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology. |
|---|---|
| Authors: | Repp ML; Department of Medicine, University of Colorado, Aurora, CO 80045, USA., Edwards MD; Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Burch CS; Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ 85308, USA., Rao A; Department of Medicine, Banner University Medicine, Tucson, AZ 85724, USA., Chinyere IR; Department of Medicine, Banner University Medicine, Tucson, AZ 85724, USA.; Sarver Heart Center, University of Arizona, 1501 North Campbell Avenue, Room 6154, Tucson, AZ 85724, USA. |
| Source: | Hearts (Basel, Switzerland) [Hearts (Basel)] 2024 Sep; Vol. 5 (3), pp. 375-388. Date of Electronic Publication: 2024 Sep 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9918300288506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2673-3846 (Electronic) Linking ISSN: 26733846 NLM ISO Abbreviation: Hearts (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
